Beryl Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-950,000
Closed -$110M 44
2023
Q3
$110M Buy
+950,000
New +$102M 12.26% 4

Other funds holding HZNP

Beryl Capital Management's HZNP Position: Q4 2023 in Review

Beryl Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,040,528 shares — an estimated $236M sold.

Beryl Capital Management first reported a position in HZNP in Q3 2023 and held it in 1 quarter. The position peaked at $236M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Beryl Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Beryl Capital Management sold 2,040,528 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $236M.
  • Beryl Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • Beryl Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $236M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Beryl Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.